Madrigal Statement on the Passing of Dr. Stephen Harrison
Madrigal Pharmaceuticals Inc MDGL
News
-
Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
Madrigal Pharmaceuticals Announces Proposed Public Offering
Madrigal's stock surges as FDA approves first drug for liver disease MASH
Madrigal Shares Leap Premarket on First FDA NASH Green Light
Madrigal Pharmaceuticals Wins Accelerated Approval for Rezdiffra From FDA
Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals Announces EMA Validation of its Marketing Authorization Application for Resmetirom for the Treatment of NASH/MASH with Liver Fibrosis
Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Thinking about trading options or stock in Palantir Technologies, Symbotic, Super Micro Computer, Madrigal Pharmaceuticals, or Futu Holdings?
Madrigal Pharmaceuticals Announces Additions to Its Leadership Team